1 completed. .
Follow Leadiant Biosciences Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX) Chenodeoxycholic Acid - Cerebrotendinous Xanthomatoses | Completed | Leadiant Biosciences Ltd. | 28 | 2014-12-09 | 2022-08-12 |
Xanthomatosis, Cerebrotendinous (1)